SCHEMBL1964541

SCHEMBL1964541

COc1cc2[nH]c(Nc3c(Cl)ccc(Cl)c3F)nc2cc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC11 Q96DB2 1/20 0.45
PTGES O14684 4/20 0.40
CLCN2 P51788 2/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
POLB P06746 2/20 0.39
KLF5 Q13887 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RET P07949 1/20 0.39
KIF5B P33176 1/20 0.39
KDR P35968 1/20 0.39
EGFR P00533 1/20 0.39
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
CSF1R P07333 1/20 0.37
HSP90AA1 P07900 2/20 0.36
PKM P14618 2/20 0.36
PAX8 Q06710 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1969313 0.89 PTGES (0.42) HDAC11PTGESPOLBKDM4EALDH1A1
SCHEMBL1968284 0.88 HDAC11 (0.52) HDAC11PTGESCLCN2NPC1RAB9A
SCHEMBL1967114 0.87 HDAC11 (0.42) HDAC11PTGESNPC1RAB9APOLB
SCHEMBL13393496 0.86 PTGES (0.54) HDAC11PTGESNPC1RAB9APOLB
SCHEMBL1970971 0.84 HDAC11 (0.45) HDAC11PTGESNPC1RAB9APOLB
SCHEMBL3134113 0.84 HDAC11 (0.54) HDAC11PTGESCLCN2NPC1RAB9A
SCHEMBL16318435 0.83 PTGES (0.49) HDAC11PTGESNPC1RAB9AALDH1A1
SCHEMBL16352233 0.83 PTGES (0.50) HDAC11PTGESRAB9A
SCHEMBL16503258 0.83 PTGES (0.50) HDAC11PTGESRAB9A
SCHEMBL16318477 0.82 PTGES (0.48) HDAC11PTGESRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US disclosed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP disclosed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 HDAC11 158/4885PTGES 118/4885CLCN2 3174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.